AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+11.9%
5Y CAGR+6.9%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+11.9%/yr
vs +8.1%/yr prior
5Y CAGR
+6.9%/yr
Recent acceleration
Acceleration
+3.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$182.40B+13.9%
2024$160.16B+21.2%
2023$132.14B+1.6%
2022$130.06B-10.8%
2021$145.85B+11.6%
2020$130.70B+23.3%
2019$105.96B+11.1%
2018$95.35B+12.5%
2017$84.76B+10.8%
2016$76.48B-